10/30/2019 Sanifit announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint in slowing the progression of cardiovascular calcification in patients on hemodialysis
03/04/2019 Data from SNF472 Phase 1b Clinical Trial published in British Journal of Clinical Pharmacology
